Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model

Archives of Ophthalmology

Volumn 129, Issue 11, 2011, Pages 1458-1465

  Wilson, Matthew W ^a,b   Jackson, John S ^a   Phillips, Blanca X ^a   Buchanan, Jacquelyn ^a   Frase, Sharon ^b   Wang, Fan ^b   Steinle, Jena J ^a   Stewart, Clinton F ^b   Mandrell, Timothy D ^a   Haik, Barrett G ^a,b   Williams, J Scott ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; FLUORESCEIN; MELPHALAN;

ADULT ANIMAL; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CHEMOTHERAPY; CHOROID; CONTROLLED STUDY; DIGITAL IMAGING; MALE; NONHUMAN; OPHTHALMIC ARTERY; OPHTHALMOSCOPY; OPTIC NERVE; PRIMATE; PRIORITY JOURNAL; RANDOMIZATION; RETINA ARTERY; RETINA EDEMA; RHESUS MONKEY; SUPERSELECTIVE INTRAOPHTHALMIC ARTERY CHEMOTHERAPY;

ANGIOGRAPHY; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARBOPLATIN; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FLUORESCEIN ANGIOGRAPHY; FLUOROSCOPY; MACACA MULATTA; MALE; MELPHALAN; OPHTHALMIC ARTERY; OPHTHALMOSCOPY; RETINAL DISEASES;

EID: 81355151025     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.330     Document Type: Article

References (25)

1. Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11(5):317-327. (Pubitemid 40310587)
2. Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12(10):1237-1246. (Pubitemid 350106354)
3. Rodriguez-Galindo C, Chantada GL, Haik BG, Wilson MW. Treatment of retinoblastoma: current status and future perspectives. Curr Treat Options Neurol. 2007; 9(4):294-307.
4. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398- 1404.
5. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623-1629.
6. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010;128(3):370-372.
7. Gobin YP, Dunkel IJ, Marr BP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience [published online ahead of print February 14, 2011]. Arch Ophthalmol. 2011;129(6):732-737.
8. Marr BP, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol. 2010;17(3):207-209.
9. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina. 2009;29(8):1207-1209.
10. Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol. 2010;38(6):638-643.
11. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203-212.
12. Vajzovic LM, Murray TG, Aziz-Sultan MA, et al. Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol. 2011;5:171-176.
13. Peterson EC, Elhammady MS, Quintero-Wolfe S, et al. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors [published online ahead of print February 4, 2011]. J Neurosurg. 2011;114(6):1603-1608.
14. Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Retina. 2011;31(3):566-573.
15. Samuels BL, Bitran JD. High-dose intravenous melphalan: a review. J Clin Oncol. 1995;13(7):1786-1799.
16. Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press; 1996.
17. Wilson MW, Zhang Q, Steinle JJ. Exposure of human retinal endothelial cells to high-dose chemotherapy upregulates inflammation and chemotaxis. Presented at: The Annual Meeting of the Association for Research in Vision and Ophthalmology; May 2011; Ft Lauderdale, Florida.
18. Li J, Jin C, Cleveland JC Jr, et al. Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin. Cardiovasc Diabetol. 2010;9:90. doi:10.1186/1475-2840-9-90.
19. Walshe TE, Connell P, Cryan L, Ferguson G, O'Brien C, Cahill PA. The role of pulsatile flow in controlling microvascular retinal endothelial and pericyte cell apoptosis and proliferation. Cardiovasc Res. 2011;89(3):661-670.
20. Lebowitz MH, Masuda JY, Beckerman JH. The pH and acidity of intravenous infusion solutions. JAMA. 1971;215(12):1937-1940.
21. Elfving G, Saikku K. Effect of pH on the incidence of infusion thrombophlebitis. Lancet. 1966;1(7444):953.
22. Fonkalsrud EW, Murphy JL, Smith FG Jr. Effect of pH in glucose infusions on development of thrombophlebitis. J Surg Res. 1968;8(11):539-543.
23. Berg SL, Aleksic A, McGuffey L, et al. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates. Cancer Chemother Pharmacol. 2004;54(2):127-130. (Pubitemid 39044241)
24. Berg SL, Stone J, Xiao JJ, et al. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates. Cancer Chemother Pharmacol. 2004;54(1):85-88. (Pubitemid 38858370)
25. Berg S, Serabe B, Aleksic A, et al. Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate. Cancer Chemother Pharmacol. 2001;47(5):385-390. (Pubitemid 32397613)